Health Economist Dominik Moser Elected to Lead Zentrum Breitenhof AG's New Board
Health Economist Dominik Moser Elected to Lead Zentrum Breitenhof AG's New Board
Health Economist Dominik Moser Elected to Lead Zentrum Breitenhof AG's New Board
Dominik Moser, a 36-year-old health economist, has been elected Chairman of the Board for Zentrum Breitenhof AG. The company's creation was approved by voters in Rüti on 28 September 2025. Moser will now lead the new governing body as it takes shape under the town council's direction.
Moser brings years of healthcare experience to the role. Currently, he heads organization and services at GZO Spital Wetzikon. Before this, he worked in process and quality management at Spital Männedorf and served as a board member for Spitex Zürichsee.
The town council has tasked him with laying the groundwork for the public-benefit corporation. His qualifications include a doctorate in health economics and further board training from the University of St. Gallen and the Swiss Board School.
Bea Dubler, head of the town's social affairs department, will represent the council on the board. Three additional members—specialising in nursing, finance, and technology—will be selected to complete the team.
With Moser at the helm, Zentrum Breitenhof AG moves forward under a board designed to blend health, financial, and technical expertise. The next steps involve finalising the remaining appointments and establishing the corporation's operational framework.
German nursing care reform faces backlash over financial risks ahead of cabinet review
A €1.8 billion annual burden on pensions. Half of care home residents at risk of welfare. Why Germany's reform is under fire—and what happens next.
Region transforms healthcare with new hospitals and modernized rural clinics
From high-tech hospitals to rural clinic revamps, this region is rewriting its healthcare story. Thousands of patients will soon benefit from expanded access and cutting-edge facilities.
FDA panel with industry ties to review peptide injection safety in July
A controversial FDA panel, stacked with doctors profiting from peptides, will decide their fate. Will science or business interests shape the outcome?
Nursing homes in crisis as low wages spark staffing shortages and delays
Thousands wait for care as underpaid staff push nursing homes to the brink. Will strikes force a pay rise—or collapse the system further?